BioGaia AB (BIOGY)
11.50
-0.58
(-4.80%)
USD |
OTCM |
Jun 28, 16:00
BioGaia Market Cap: 1.161B for June 28, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 28, 2024 | 1.161B |
| June 27, 2024 | 1.220B |
| June 26, 2024 | 1.220B |
| June 21, 2024 | 1.220B |
| June 20, 2024 | 1.220B |
| June 18, 2024 | 1.220B |
| June 17, 2024 | 1.220B |
| June 14, 2024 | 1.220B |
| June 13, 2024 | 1.220B |
| June 12, 2024 | 1.220B |
| June 11, 2024 | 1.220B |
| June 10, 2024 | 1.220B |
| June 07, 2024 | 1.220B |
| June 06, 2024 | 1.220B |
| June 05, 2024 | 1.220B |
| June 04, 2024 | 1.220B |
| June 03, 2024 | 1.220B |
| May 31, 2024 | 1.220B |
| May 30, 2024 | 1.220B |
| May 29, 2024 | 1.185B |
| May 28, 2024 | 1.185B |
| May 24, 2024 | 1.161B |
| May 23, 2024 | 1.161B |
| May 22, 2024 | 1.161B |
| May 21, 2024 | 1.161B |
| Date | Value |
|---|---|
| May 20, 2024 | 1.161B |
| May 17, 2024 | 1.161B |
| May 16, 2024 | 1.161B |
| May 15, 2024 | 1.161B |
| May 14, 2024 | 1.161B |
| May 13, 2024 | 1.161B |
| May 10, 2024 | 1.161B |
| May 09, 2024 | 1.161B |
| May 08, 2024 | 1.161B |
| May 07, 2024 | 1.161B |
| May 06, 2024 | 981.55M |
| May 03, 2024 | 981.55M |
| May 02, 2024 | 981.55M |
| May 01, 2024 | 981.55M |
| April 30, 2024 | 981.55M |
| April 29, 2024 | 981.55M |
| April 26, 2024 | 981.55M |
| April 25, 2024 | 981.55M |
| April 24, 2024 | 981.55M |
| April 23, 2024 | 981.55M |
| April 22, 2024 | 981.55M |
| April 19, 2024 | 981.55M |
| April 18, 2024 | 981.55M |
| April 17, 2024 | 1.221B |
| April 16, 2024 | 1.221B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
695.19M
Minimum
Apr 13 2020
1.667B
Maximum
May 26 2022
987.97M
Average
991.65M
Median
May 15 2023
Market Cap Benchmarks
| Abliva AB | 13.49M |
| Karolinska Development AB | 69.51M |
| Calliditas Therapeutics AB | 1.047B |
| Oncopeptides AB | 23.97M |
| Olink Holding AB | 3.168B |
Market Cap Related Metrics
| PE Ratio | 32.90 |
| PS Ratio | 9.43 |
| Price to Book Value | 5.706 |
| Price to Free Cash Flow | 38.10 |
| Price | 11.50 |
| Earnings Yield | 3.04% |
| Operating PE Ratio | 28.09 |
| Normalized PE Ratio | 32.90 |